Evidence-Based Medicine Guidelines
Chronic myelogenous leukaemia (CML)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Chronic Myelogenous Leukaemia (CML)." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453662/all/Chronic_myelogenous_leukaemia__CML_.
Chronic myelogenous leukaemia (CML). Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/453662/all/Chronic_myelogenous_leukaemia__CML_. Accessed November 23, 2024.
Chronic myelogenous leukaemia (CML). (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/453662/all/Chronic_myelogenous_leukaemia__CML_
Chronic Myelogenous Leukaemia (CML) [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453662/all/Chronic_myelogenous_leukaemia__CML_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Chronic myelogenous leukaemia (CML)
ID - 453662
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453662/all/Chronic_myelogenous_leukaemia__CML_
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
